Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1982 May;76(1):77–83. doi: 10.1111/j.1476-5381.1982.tb09192.x

Rate-limiting step in the metabolism of polar and non-polar monoamines in lung and liver.

R R Ben-Harari, R Peleg, M B Youdim
PMCID: PMC2068754  PMID: 6805544

Abstract

1 Uptake of the non-hydroxylated amines, [14C]-tryptamine and [14C]-benzylamine in rat lung, infused through the pulmonary circulation, was not saturable over the concentration range 2.5-1,000 microM. 2 The kinetic constants for deamination of a variety of hydroxylated and non-hydroxylated monoamines in liver, perfused via the portal circulation, with monoamine oxidase activity in homogenates of liver were similar. 3 In lung, uptake of both [14C]-tryptamine and [14C]-benzylamine was inhibited by the monoamine oxidase inhibitor deprenyl and competition occurred between tryptamine, benzylamine and beta-phenylethylamine for uptake. 4 These results indicate that tryptamine and benzylamine metabolism in lung is not limited by uptake, unlike that of the hydroxylated amines 5-hydroxytryptamine and noradrenaline and that uptake resembles that of beta-phenylethylamine in lung. 5 the selectivity of the lung in handling monoamines is not shown by the liver, suggesting that lung has a specific role in clearing certain biogenic monoamines.

Full text

PDF
77

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alabaster V. A., Bakhle Y. S. Removal of 5-hydroxytryptamine in the pulmonary circulation of rat isolated lungs. Br J Pharmacol. 1970 Nov;40(3):468–482. [PMC free article] [PubMed] [Google Scholar]
  2. Anderson M. W., Orton T. C., Pickett R. D., Eling T. E. Accumulation of amines in the isolated perfused rabbit lung. J Pharmacol Exp Ther. 1974 May;189(2):456–466. [PubMed] [Google Scholar]
  3. Bakhle Y. S., Vane J. R. Pharmacokinetic function of the pulmonary circulation. Physiol Rev. 1974 Oct;54(4):1007–1045. doi: 10.1152/physrev.1974.54.4.1007. [DOI] [PubMed] [Google Scholar]
  4. Bakhle Y. S., Youdim M. B. The metabolism of 5-hydroxytryptamine and beta-phenylethylamine in perfused rat lung and in vitro. Br J Pharmacol. 1979 Jan;65(1):147–154. doi: 10.1111/j.1476-5381.1979.tb17343.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ben-Harari R. R., Bakhle Y. S. Uptake of beta-phenylethylamine in rat isolated lung. Biochem Pharmacol. 1980 Feb 15;29(4):489–494. doi: 10.1016/0006-2952(80)90367-6. [DOI] [PubMed] [Google Scholar]
  6. Braestrup C., Andersen H., Randrup A. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation. Eur J Pharmacol. 1975 Nov;34(1):181–187. doi: 10.1016/0014-2999(75)90238-1. [DOI] [PubMed] [Google Scholar]
  7. Dollery C. T., Junod A. F. Concentration of (+/-)-propranolol in isolated, perfused lungs of rat. Br J Pharmacol. 1976 May;57(1):67–71. doi: 10.1111/j.1476-5381.1976.tb07657.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ekstedt B. Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria. Biochem Pharmacol. 1976 May 15;25(10):1133–1138. doi: 10.1016/0006-2952(76)90359-2. [DOI] [PubMed] [Google Scholar]
  9. Finberg J. P., Tenne M., Youdim M. B. Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B. Br J Pharmacol. 1981 May;73(1):65–74. doi: 10.1111/j.1476-5381.1981.tb16772.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gabay S., Valcourt A. J. Studies of monoamine oxidases. I. Purification and properties of the rabbit liver mitochondrial enzyme. Biochim Biophys Acta. 1968 Jul 9;159(3):440–450. doi: 10.1016/0005-2744(68)90128-9. [DOI] [PubMed] [Google Scholar]
  11. Hems R., Ross B. D., Berry M. N., Krebs H. A. Gluconeogenesis in the perfused rat liver. Biochem J. 1966 Nov;101(2):284–292. doi: 10.1042/bj1010284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Houslay M. D., Tipton K. F. A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes. Biochem J. 1974 Jun;139(3):645–652. doi: 10.1042/bj1390645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Junod A. F. Uptake, metabolism and efflux of 14 C-5-hydroxytryptamine in isolated perfused rat lungs. J Pharmacol Exp Ther. 1972 Nov;183(2):341–355. [PubMed] [Google Scholar]
  14. Krajl M. A rapid microfluorimetric determination of monoamine oxidase. Biochem Pharmacol. 1965 Nov;14(11):1684–1686. doi: 10.1016/0006-2952(65)90025-0. [DOI] [PubMed] [Google Scholar]
  15. NAKAJIMA T., KAKIMOTO Y., SANO I. FORMATION OF BETA-PHENYLETHYLAMINE IN MAMMALIAN TISSUE AND ITS EFFECT ON MOTOR ACTIVITY IN THE MOUSE. J Pharmacol Exp Ther. 1964 Mar;143:319–325. [PubMed] [Google Scholar]
  16. Nicholas T. E., Strum J. M., Angelo L. S., Junod A. F. Site and mechanism of uptake of 3H--norepinephrine by isolated perfused rat lungs. Circ Res. 1974 Nov;35(5):670–680. doi: 10.1161/01.res.35.5.670. [DOI] [PubMed] [Google Scholar]
  17. Oldendorf W. H. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol. 1971 Dec;221(6):1629–1639. doi: 10.1152/ajplegacy.1971.221.6.1629. [DOI] [PubMed] [Google Scholar]
  18. Simpson L. L. Evidence that deprenyl, A type B monoamine oxidase inhibitor, is an indirectly acting sympathomimetic amine. Biochem Pharmacol. 1978;27(11):1591–1595. doi: 10.1016/0006-2952(78)90490-2. [DOI] [PubMed] [Google Scholar]
  19. White H. L., Wu J. C. Multiple binding sites of human brain monoamine oxidase as indicated by substrate competition. J Neurochem. 1975 Jul;25(1):21–26. doi: 10.1111/j.1471-4159.1975.tb07688.x. [DOI] [PubMed] [Google Scholar]
  20. Woods H. F., Eggleston L. V., Krebs H. A. The cause of hepatic accumulation of fructose 1-phosphate on fructose loading. Biochem J. 1970 Sep;119(3):501–510. doi: 10.1042/bj1190501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Youdim M. B., Woods H. F. The influence of tissue environment on the rates of metabolic processes and the properties of enzymes. Biochem Pharmacol. 1975 Feb 1;24(3):317–323. doi: 10.1016/0006-2952(75)90212-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES